Sentences with phrase «gladstone center»

Stephen B. Freedman, PhD, is Director of the Gladstone Center for Translational Research and Vice President for Corporate Liaison and Ventures at the Gladstone Institutes.

In 2006, he developed the Gladstone Center for Translational Research to facilitate the movement of some aspects of Gladstone's basic research into developmental targets.

Funding was provided by the National Institute of Allergy and Infectious Diseases, the Hellmans Fellow Fund, the UCSF - Gladstone Center for AIDS Research (CFAR), Creative and Novel Ideas in HIV Research, and a California Institute for Regenerative Medicine / Gladstone Institutes fellowship.

Funding was provided by the National Heart, Lung, and Blood Institute, National Institute of Child Health and Human Development, National Institute of Drug Abuse, National Institute of General Medical Sciences, California Institute for Regenerative Medicine, Howard Hughes Medical Institute, Canadian Institutes of Health Research, Agilent University Relations, Uehara Memorial Foundation Research, and the UCSF - Gladstone Center for AIDS Research.

The research was supported by the National Institutes of Health grants R21 AI102782, P30 AI027763 (UCSF - Gladstone Center for AIDS Research), 1DP1036502 (Avant - Garde Award for HIV / AIDS Research), U19 AI0961133 (Martin Delaney CARE Collaboratory), the A.P. Giannini Postdoctoral Research Fellowship and the UCSF / Robert John Sabo Trust Award.

The research was supported by the National Institutes of Health grants R21 AI102782, P50 GM082250, P01 AI090935, P50 GM081879, P30 AI027763 (UCSF - Gladstone Center for AIDS Research), 1DP1036502 (Avant - Garde Award for HIV / AIDS Research), U19 AI0961133 (Martin Delaney CARE Collaboratory); and the A.P. Giannini Postdoctoral Research Fellowship.

Stephen B. Freedman, PhD, is Director of the Gladstone Center for Translational Research (GCTR) and Vice President for Corporate Liaison and Ventures at the Gladstone Institutes.

The Gladstone Center for Cell Circuitry (GC3) addresses this fundamental challenge by developing single - cell tools to map how cellular components connect into circuits.

«We are proposing an innovative and comprehensive approach to fill a major gap in HIV cure research,» said project lead Warner C. Greene, MD, PhD, director of the Gladstone Institute of Virology and Immunology and co-director of the UCSF - Gladstone Center for AIDS Research.

In contrast to reductionist methods that study elements of a system in isolation, the Gladstone Center for Systems and Therapeutics investigates systems holistically.

Not exact matches

Under the guidance of Chef David Felton and Chef Martin Kester, Chef Devino spent three years at Ninety Acres Culinary Center in Peapack - Gladstone, New Jersey.

After several years as a bioinformatics postdoc at the Gladstone Institute of Cardiovascular Disease, located at UCSF's Medical Center at Mission Bay, Pico's next logical step would have been to start his own lab.

Sheng Ding, PhD, a senior investigator in the Roddenberry Stem Cell Center at Gladstone and co-senior author on the study, adds, «This new cellular reprogramming and expansion paradigm is more sustainable and scalable than previous methods.

Shinya Yamanaka, MD, PhD, a UCSF professor of anatomy and a senior investigator with the UCSF - affiliated Gladstone Institutes, as well as the director of the Center for iPSCell Research and Application (CiRA) and a principal investigator at Kyoto University, shared the Nobel Prize in 2012 for discovering how to make iPS cells from skin cells using a handful of protein «factors.»

Arizona State University Army Research Lab, Weapons and Materials Research Directorate Baylor School of Medicine Carnegie Mellon University Case Western Reserve University CIIT Centers for Health Research Columbia University Cornell University Emory University School of Medicine Fred Hutchinson Cancer Research Center J. David Gladstone Institute Harvard University Medical School Indiana University, Bloomington Johns Hopkins School of Medicine Los Alamos National Laboratory Lawrence Livermore National Laboratory Louisiana State University Health Sciences Center Massachusetts General Hospital Massachusetts Institute of Technology McGill University MCP Hahnemann Medical School Medical College of Georgia Medical College of Wisconsin Microsoft NCI NIEHS NIH NOAA New York University School of Medicine Penn State University College of Medicine Pfizer Rockefeller University Rowland Institute for Science Seattle Biomedical Research Institute St. Jude Children's Research Hospital Stanford University USEPA / National Risk Management Research Lab University of Alabama, Birmingham University of California, Berkeley University of California, Los Angeles University of California, San Diego University of California, San Francisco University of Chicago University of Cincinnati College of Medicine University of Colorado at Boulder University of Georgia University of Illinois, Chicago University of Illinois, Urbana - Champagne University of Maryland University of Medicine and Dentistry of New Jersey University of Michigan University of Minnesota University of New Mexico University of North Carolina, Chapel Hill University of Pennsylvania University of Rochester School of Medicine and Dentistry University of Texas, Austin University of Texas Medical Branch University of Toronto University of Wisconsin, Madison Vanderbilt University Virginia Tech Yale University

The first group of winners includes Cornelia I. Bargmann of Rockefeller University in New York City; David Botstein of Princeton University; Lewis C. Cantley of Weill Cornell Medical College in New York City; Hans Clevers of the Hubrecht Institute in the Netherlands; Napoleone Ferrara of the University of California, San Diego; Titia de Lange of Rockefeller University; Eric S. Lander of Harvard University and the Massachusetts Institute of Technology (MIT) in Cambridge; Charles L. Sawyers of Memorial Sloan - Kettering Cancer Center in New York City; Bert Vogelstein of Johns Hopkins University in Baltimore, Maryland; Robert A. Weinberg of MIT; and the 2012 Nobel laureate Shinya Yamanaka of Kyoto University and the Gladstone Institutes in San Francisco.

Steve Finkbeiner, MD, PhD, senior investigator and director of the Taube - Koret Center for Neurodegenerative Disease Research at Gladstone Institutes, is part of this Huntington's disease research program.

After serving as a Senior Investigator at the National Cancer Institute and a Professor of Medicine and Howard Hughes Investigator at Duke University Medical Center, Dr. Greene accepted his current position as the Founding Director of the Gladstone Institute of Virology and Immunology in 1991.

For example, she directs Gladstone's Center for In Vivo Imaging Research, which analyzes high - resolution and cutting - edge in vivo images to monitor molecular changes in the brains of live animals over time.

Funding for the research came from the UCSF Liver Center, the Gladstone Institutes, and the National Institutes of Health.

In part, the Center builds on pioneering work done by Gladstone Senior Investigator Shinya Yamanaka, MD, PhD — who currently divides his time between Gladstone and Kyoto University's Center for iPS Cell Research and Application (CiRA).

Gladstone Postdoctoral Fellow Roy Dar, PhD, also contributed to this research, which was supported by the National Institutes of Health, the Pew Charitable Trust, the Center for Nanophase Materials Sciences (United States Department of Energy), the National Science Foundation Graduate Research Fellowship Program and the National Cancer Institutes.

Foundation helped launch the Center for Comprehensive Alzheimer's Disease Research at Gladstone with a generous $ 6M lead gift.

Senior Investigator, Gladstone Institute of Neurological Disease Director, Center for Translational Advancement

The Center is also an example of how Gladstone leverages donations for maximum benefit to patients.

Srivastava, who pioneered the use of stem cells for heart disease, is director of the Roddenberry Stem Cell Center and a senior investigator at the Gladstone Institutes.

The Hellman Family Foundation Alzheimer's Research Program at Gladstone, which operates in collaboration with the Memory and Aging Center at the University of California, San Francisco (UCSF), leverages infrastructure, resources and research from Gladstone's existing Taube - Koret Center for Huntington's Disease Research.

In 2010, the Gladstone Institutes established the Center for In Vivo Imaging Research (CIVIR).

President, Gladstone Institutes Director, Roddenberry Stem Cell Center Senior Investigator & Director, Gladstone Institute of Cardiovascular Disease

Gladstone founded the Roddenberry Center for Stem Cell Biology and Medicine in 2011 with an unprecedented $ 5M gift from the Roddenberry Foundation.

Both scientists continue their research at the Gladstone Institutes and at the Center for iPS Cell Research and Application in Kyoto, Japan.

«Lorenz has already made great strides in his quest to translate his findings to the clinic,» said Deepak Srivastava, MD, director of the Roddenberry Stem Cell Center at the Gladstone Institutes, and member of the prize's selection committee.

Researchers Matthew Porteus, MD, PhD, associate professor of pediatrics at Stanford School of Medicine; Frank Longo, MD, PhD, professor of neurology at Stanford School of Medicine; and Steve Finkbeiner, MD, PhD, director of the Gladstone Institutes» Taube - Koret Center for Neurodegenerative Disease Research, will collaborate with clinical efforts at the UCSF Memory and Aging Center, under the direction of Bruce Miller, MD, PhD.

«This is going to be transformative,» said Finkbeiner, who is the director of the Center for Systems and Therapeutics at Gladstone in San Francisco.

Before joining Gladstone in 1991 as the Founding Director of the Gladstone Institute of Virology and Immunology, Dr. Greene served as a Senior Investigator at the National Cancer Institute and a Professor of Medicine and Howard Hughes Investigator at Duke University Medical Center.

An international team of scientists contributed to this research, including Jennifer Yokoyama, of UCSF; Lei Zhu, of UCSF and Gladstone; Lauren Broestl, of UCSF; Kurtresha Worden of Gladstone and UCSF; Dan Wang, of UCSF; Virginia Sturm, of UCSF; Daniel Kim of Gladstone; Eric Klein of UCLA; Gui - Qiu Yu, of Gladstone; Kaitlyn Ho of Gladstone; Kirsten Eilertson of Gladstone; Lei Yu, of Rush University Medical Center; Makoto Kuro - o of UT Southwestern Medical Center and Jichi Medical University; Philip De Jager, of Brigham and Women's Hospital, Harvard Medical School and the Broad Institute; Giovanni Coppola, of UCLA; Gary Small, of UCLA; David Bennett, of Rush; Joel Kramer, of UCSF; Carmela Abraham, of Boston University; and Bruce Miller, of UCSF.

In 2009, Gladstone joined forces with Taube Philanthropies and the Koret Foundation to found the Taube / Koret Center for Huntington's Disease Research.

She joined Gladstone along with Sheng Ding, PhD, after completing her MD at Peking University Health Science Center, and her PhD in developmental biology at Tsinghua University.

Senior Investigator, Gladstone Institutes; Director of the Center for iPS Cell Research and Application, Kyoto University

Deepak Srivastava, MD - President, Gladstone Institutes Steve Finkbeiner, MD, PhD - Director, Center of Systems and Therapeutics Warner C. Greene, MD, PhD - Director, Center for HIV Cure Research Lennart Mucke, MD - Director, Gladstone Institute of Neurological Disease Katherine S. Pollard, PhD - Director, Gladstone Institute of Data Science and Biotechnology

Deepak Srivastava, MD Director of the Gladstone Institute of Cardiovascular Disease and Director of the Roddenberry Stem Cell Center, Gladstone Institutes

Before joining Gladstone in 2005, Dr. Srivastava was a Professor in the Department of Pediatrics and Molecular Biology at the University of Texas Southwestern (UTSW) Medical Center in Dallas.

Speakers from Gladstone and other centers of excellence from across the US will discuss the latest exciting developments in research on important major brain diseases and related fields of neuroscience.

This grim prospect is what stem cell scientists, like Dr. Deepak Srivastava, Director of Cardiovascular Disease and the Stem Cell Center at the Gladstone Institutes in San Francisco, are hoping to change.

Eirini Vagena also participated in this research at Gladstone, which was supported by the Spanish Ministry of Education and Science, the UCSF Liver Center, the UCSF Diabetes and Endocrinology Center and the National Institutes of Health.

Scientific co-founders of the company include Srivastava and Gladstone Investigators Benoit Bruneau, PhD, Bruce Conklin, MD, Sheng Ding, PhD, and Saptarsi Haldar, MD, as well as Eric Olson, PhD, from the University of Texas Southwestern Medical Center.

Gladstone Investigator Ken Nakamura, MD, PhD, and the National Institutes of Health Investigator Mark Cookson, PhD, also participated in this research, which was supported by the following: the de Clercq Family, the National Center for Research Resources (#RR189288), the Burroughs - Wellcome Medical Scientist Fund, the National Institute of Neurological Disorders and Stroke (#P30NS069496), the National Institute on Aging, the Taube - Koret Center for Huntington's Disease Research, the Hellman Family Foundation, the California Institute for Regenerative Medicine (#RB4 -06079) and the National Institutes of Health (#U24 NS078370, # 3R01 NS039074, # 2R01 NS04549).

In 2007, he became a senior investigator at Gladstone, where he currently conducts his research at the Roddenberry Stem Cell Center.

Dr. Yamanaka, who did his postdoctoral training at Gladstone in the 1990s, also directs the Center for iPS Cell Research and Application (CiRA), and is a principal investigator at the Institute for Integrated Cell - Material Sciences (iCeMS)-- both located at Japan's Kyoto University.

This research, which was performed at the Roddenberry Center for Stem Cell Biology and Medicine at Gladstone, has also revealed the precise role of Sox2 as a master regulator that controls the identity of neural stem cells.